DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
8.82
-0.29 (-3.24%)
Oct 16, 2026, 10:36 AM EDT - Market open
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $520.63 million as of October 16, 2026. Its market cap has increased by 19.38% in one year.
Market Cap
520.63M
Enterprise Value
356.67M
1-Year Change
19.38%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $520.63M, a decrease of -38.37%. That is a compound annual growth rate of -3.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 520.63M | -19.70% |
| Dec 31, 2025 | 648.40M | 987.92% |
| Dec 31, 2024 | 59.60M | -67.52% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
| Oct 22, 2014 | 844.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 575.07M |
| Silence Therapeutics | 558.14M |
| Electra Therapeutics | 551.72M |
| Puma Biotechnology | 546.66M |
| Valneva SE | 545.31M |
| Faeth Therapeutics | 542.39M |
| Shattuck Labs | 540.96M |
| Crescent Biopharma | 534.37M |